Home
>
National Drug Code (NDC)
>
docetaxel
docetaxel - 25021-222-04 - (docetaxel)
Drug Information of docetaxel
| Product NDC: | 25021-222 |
| Proprietary Name: | docetaxel |
| Non Proprietary Name: | docetaxel |
| Active Ingredient(s): | 20 mg/mL & nbsp; docetaxel |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of docetaxel
| Product NDC: | 25021-222 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA203551 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130701 |
Package Information of docetaxel
| Package NDC: | 25021-222-04 |
| Package Description: | 1 VIAL in 1 CARTON (25021-222-04) > 4 mL in 1 VIAL |
NDC Information of docetaxel
| NDC Code | 25021-222-04 |
| Proprietary Name | docetaxel |
| Package Description | 1 VIAL in 1 CARTON (25021-222-04) > 4 mL in 1 VIAL |
| Product NDC | 25021-222 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | docetaxel |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130701 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | DOCETAXEL |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
